||The impact of
statin therapy on CRP was evaluated in these data from the Cholesterol and Recurrent
Events (CARE) trial, in which CRP levels were found to predict recurrent coronary events
in patients who had a prior history of myocardial infarction.
Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E, for
the Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and
the risk of coronary events after myocardial infarction in patients with average
cholesterol levels. Circulation 1998;98:839-844.